LIBERTAS QRS Trademark

Trademark Overview


On Monday, October 28, 2024, a trademark application was filed for LIBERTAS QRS with the United States Patent and Trademark Office. The USPTO has given the LIBERTAS QRS trademark a serial number of 98825009. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 29, 2025. This trademark is owned by Maxx Orthopedics, Inc.. The LIBERTAS QRS trademark is filed in the Medical Instrument Products category with the following description:

Orthopedic joint implants; medical and surgical instrumentation used in orthopedic transplant and implant surgery
libertas qrs

General Information


Serial Number98825009
Word MarkLIBERTAS QRS
Filing DateMonday, October 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, April 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkLIBERTAS Q R S
Goods and ServicesOrthopedic joint implants; medical and surgical instrumentation used in orthopedic transplant and implant surgery

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, October 28, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMaxx Orthopedics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorristown, PA 19403

Trademark Events


Event DateEvent Description
Tuesday, October 29, 2024NEW APPLICATION ENTERED
Monday, April 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 29, 2025ASSIGNED TO EXAMINER
Tuesday, April 29, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 29, 2025NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED